Mainly engaged in research of drug design and new methods of organic synthesis. (1) Design and synthesis of epigenetic protein small molecule regulators (2) R&D of "targeted therapy" drugs for neurological diseases and cancer (3) Application of new organic synthesis methods in drug research and development